# RTIRE (NCT05345444)

> Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05345444
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Weill Medical College of Cornell University
- Conditions: Prostate Cancer
- Interventions: IRE & MRgRT
- Enrollment: 48
- Primary outcome: Feasibility as measured by percentage of subjects assessed at 12 weeks post-IRE
- Primary outcome: Feasibility as measured by percentage of subjects assessed at 6 weeks post-MRgRT within 1 year
- Primary outcome: Proportion of patients who remain cancer-free

## Commentary we found

- YouTube: 9
- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=rtire-nct05345444

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05345444", "email": "<work email>"}; the inbox owner confirms by the emailed link.